SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (748)10/22/1999 12:41:00 PM
From: scaram(o)uche  Read Replies (1) of 4474
 
What do you have to say about Berger removing well
liked scientists?

I don't have enough data to comment. I can say that I have never liked Berger. He is more responsible, IMO, for biotech's most embarrassing moments -- those ass'd with a molecule known as HA-1A -- than anyone else.

That sort of arrogance is rare. The guy played a large roll in taking Centocor down the drain, and the company was only able to recover when he and others left or were purged.

I don't agree with you that the recovery was masterful. I do agree that the sale of ARIA interests in the Genomics Center lends viability. However, the BOD is not doing its job if they leave Berger and LaMarche in their positions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News